[1]
N. SGHERZA, A. Mestice, A. M. V. Larocca, and P. Musto, “Antibody response to breakthrough SARS-CoV-2 infection in ‘booster’ vaccinated patients with multiple myeloma according to B/T/NK lymphocyte absolute counts and anti-CD38 treatments”, Mediterr J Hematol Infect Dis, vol. 16, no. 1, p. e2024022, Feb. 2024.